| Style | Citing Format |
|---|---|
| MLA | Forouzannia S A, et al.. "Application of Radiomics in Abdominal Aortic Aneurysm and Endovascular Aneurysm Repair-Related Adverse Events Imaging: A Systematic Review." CVIR Endovascular, vol. 9, no. 1, 2026, pp. -. |
| APA | Forouzannia S A, Khalaj F, Ghorani H, Rafiei Alavi S R, Broomand Lomer N, Moradi N, Astani S A (2026). Application of Radiomics in Abdominal Aortic Aneurysm and Endovascular Aneurysm Repair-Related Adverse Events Imaging: A Systematic Review. CVIR Endovascular, 9(1), -. |
| Chicago | Forouzannia S A, Khalaj F, Ghorani H, Rafiei Alavi S R, Broomand Lomer N, Moradi N, Astani S A. "Application of Radiomics in Abdominal Aortic Aneurysm and Endovascular Aneurysm Repair-Related Adverse Events Imaging: A Systematic Review." CVIR Endovascular 9, no. 1 (2026): -. |
| Harvard | Forouzannia S A et al. (2026) 'Application of Radiomics in Abdominal Aortic Aneurysm and Endovascular Aneurysm Repair-Related Adverse Events Imaging: A Systematic Review', CVIR Endovascular, 9(1), pp. -. |
| Vancouver | Forouzannia S A, Khalaj F, Ghorani H, Rafiei Alavi S R, Broomand Lomer N, Moradi N, et al.. Application of Radiomics in Abdominal Aortic Aneurysm and Endovascular Aneurysm Repair-Related Adverse Events Imaging: A Systematic Review. CVIR Endovascular. 2026;9(1):-. |
| BibTex | @article{ author = {Forouzannia S A and Khalaj F and Ghorani H and Rafiei Alavi S R and Broomand Lomer N and Moradi N and Astani S A}, title = {Application of Radiomics in Abdominal Aortic Aneurysm and Endovascular Aneurysm Repair-Related Adverse Events Imaging: A Systematic Review}, journal = {CVIR Endovascular}, volume = {9}, number = {1}, pages = {-}, year = {2026} } |
| RIS | TY - JOUR AU - Forouzannia S A AU - Khalaj F AU - Ghorani H AU - Rafiei Alavi S R AU - Broomand Lomer N AU - Moradi N AU - Astani S A TI - Application of Radiomics in Abdominal Aortic Aneurysm and Endovascular Aneurysm Repair-Related Adverse Events Imaging: A Systematic Review JO - CVIR Endovascular VL - 9 IS - 1 SP - EP - PY - 2026 ER - |